Correction to: Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
-
Published:2021-07
Issue:3
Volume:18
Page:2126-2126
-
ISSN:1933-7213
-
Container-title:Neurotherapeutics
-
language:en
-
Short-container-title:Neurotherapeutics
Author:
Hartung Hans-Peter,Mares Jan,Meuth Sven G.,Berger Thomas
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology